男女羞羞视频在线观看,国产精品黄色免费,麻豆91在线视频,美女被羞羞免费软件下载,国产的一级片,亚洲熟色妇,天天操夜夜摸,一区二区三区在线电影

HK-Shenzhen pulls off a first under medical connect

By Chai Hua | HK EDITION | Updated: 2021-05-21 14:26
Share
Share - WeChat
Management teams from the University of Hong Kong-Shenzhen Hospital and China Resources Guangdong Pharmaceutical pose for a group photo with the first imported medicine and medical device under the connect on April 16. [Photo provided to China Daily]

Moreover, he said the new channel can expand sales of medical companies. The hospital is purchasing a further 10 titanium rods. Each patient needs only one or two rods.

Lo said safety concerns will ensure the quantity won't be extremely large initially. "The titanium rod producer has agreed to provide the equipment on the mainland because they knew Professor Cheung would perform the surgery," he added, stressing the result of each case is important for the drug and medical equipment producers.

According to HKU-SZH, four other innovative medications have been approved and will soon be put into pilot use at the hospital, following the first drug and device applications.

The first imported medicine under the connect program is Rho(D) immune globulin - a blood disease drug that was used clinically at the hospital on April 29. In addition, the clinical data collected from these applications could also help expedite national approval for related international drugs or devices.

The marketing of many medicines in Hong Kong is synchronized with the world because of mutual recognition, but the mainland needs to do its own clinical results for review and approval, said Huo Peiqiong, general manager of China Resources Guangdong Pharmaceutical - the import agent for the first drugs and equipment.

So registering in Hong Kong or launching the products in the Hong Kong market is much faster than on the mainland, she noted. For example, one drug can be listed in Hong Kong simultaneously in the United States or the United Kingdom.

The connect gives the green light for medicines that are already available in Hong Kong and Macao markets, so more international pharmaceutical enterprises would seek registration there because entering the two special administrative regions mean they could tap the Greater Bay Area or the entire mainland market sooner.

However, it wasn't plain sailing for reviewing, purchasing and transporting the first batch of drugs and device through the connect. Huo recalled it took more than two months to have them delivered.

Many innovative measures were needed to lay a solid foundation for the potential expansion of the connect to more mainland cities. But in the absence of national approval, the import agent had to communicate back and forth between local evaluation authorities and pharmaceutical enterprises to provide proper materials for review.

|<< Previous 1 2 3 4 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 武山县| 禹城市| 邢台市| 温州市| 亳州市| 凤翔县| 延长县| 集贤县| 花莲县| 渑池县| 晋城| 清水县| 轮台县| 乌鲁木齐县| 凤冈县| 兴和县| 凤翔县| 平顺县| 沾益县| 陵川县| 连南| 红河县| 台安县| 永嘉县| 蒙城县| 宝坻区| 兰州市| 昂仁县| 江津市| 东宁县| 六枝特区| 安丘市| 招远市| 乳山市| 且末县| 太谷县| 启东市| 永福县| 丽江市| 武安市| 玉树县| 山东省| 博客| 丰县| 崇明县| 固阳县| 观塘区| 正安县| 牟定县| 澎湖县| 安陆市| 蒲江县| 云安县| 肥城市| 邵阳市| 宁津县| 凤城市| 电白县| 云霄县| 金沙县| 观塘区| 鲜城| 油尖旺区| 渑池县| 大渡口区| 玛多县| 班戈县| 塔河县| 祁连县| 和平区| 德兴市| 酒泉市| 台东县| 富川| 睢宁县| 闽侯县| 会宁县| 南涧| 兴隆县| 宁远县| 六盘水市| 新和县|